Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome
- Authors: Drapkina OM1, Zyatenkova EV2
-
Affiliations:
- «ГНИЦ профилактической медицины»
- «Первый МГМУ им. И. М. Сеченова»
- Issue: Vol 88, No 2 (2016)
- Pages: 64-70
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31922
- ID: 31922
Cite item
Full Text
Abstract
About the authors
O M Drapkina
«ГНИЦ профилактической медицины»Москва, Россия
E V Zyatenkova
«Первый МГМУ им. И. М. Сеченова»Москва, Россия
References
- Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5:167-173. doi: 10.1002/9780470988107.ch2.
- Драпкина О.М., Драпкина Ю.С. Фиброз сердца и печени: составляющие одного уравнения. Кардиология. 2014;9:4-8. doi: 10.18565/cardio.2014.9.57-62.
- Korneeva ON, Drapkina OM, Ivashkin VT. Predictive value of epicardial fat as new marker of metabolic syndrome and early vascular damage in patient with NAFLD. J Hepatol. 2013;58:S543. doi: 10.1016/s0168-8278(13)61348-3.
- Silaghi AC, Poantă L, Valea A, Pais R, Silaghi H. Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction? Med Ultrason. 2011;13:15-20. doi: 10.2478/s11536-011-0011-7.
- Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11:304-310. doi: 10.1038/oby.2003.45.
- Iacobellis G. Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol. 2007;115:272-273. doi: 10.1016/j.ijcard.2006.04.016.
- Bonapace S, Valbusa F, Bertolini L, Pichiri I. Nonalcoholic Fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus. PLoS One. 2014;9(2):e88371. doi: 10.1371/journal.pone.0088371.
- Iacobellis G, Barbarini G, Letizia C, Barbaro G. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity. 2014;22(2):332-336. doi: 10.1002/oby.20624.
- Gastaldelli A, Kozakova M, Højlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology. 2009;49:1537-1544. doi: 10.1002/hep.22845.
- Angulo P, Hui J, Marchesini G et al. The NAFLD Fibrosis Score: A Noninvasive System That Identifies Liver Fibrosis in Patients with NAFLD. Hepatology. 2007;4(45):846-854. doi: 10.1002/hep.21496.
- Iacobellis G, Zaki MC, Garcia D, Willens HJ. Epicardial fat in atrial fibrillation and heart failure. Hormone Metabol Res. 2014;46(8):587-589. doi: 10.1055/s-0034-1367078.
- Suzuki A, Lymp J, Sauver JS, Angulo P, Lindor K. Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. LiverInt. 2006;26:1209-1216. doi: 10.1111/j.1478-3231.2006.01362.x.
- Banu D. Ozel Coskin еt al. Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol. 2015;27:142-149. doi: 10.1097/meg.0000000000000264.
Supplementary files
